Cannabinoid agonists stimulate [ 3H]GABA release in the globus pallidus of the rat when Gj protein-receptor coupling is restricted: Role of dopamine D2 receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 3, 2009, Pages 822-828

  Gonzalez, Brenda ^a   Paz, Francisco ^a   Florán, Leonor ^a   Aceves, Jorge ^a   Erlij, David ^b   Florán, Benjamín ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID; ARACHIDONYL 2 CHLOROETHYLAMIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; DOPAMINE 2 RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; N ETHYLMALEIMIDE; PERTUSSIS TOXIN; RESERPINE; SULPIRIDE; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; GLOBUS PALLIDUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT;

ANIMALS; ARACHIDONIC ACIDS; BENZOXAZINES; CANNABINOIDS; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; MALE; MORPHOLINES; NAPHTHALENES; PERTUSSIS TOXIN; RATS; RATS, WISTAR; RESERPINE; TRITIUM;

EID: 62449156259     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.145425     Document Type: Article

References (42)

1. Bash R, Ruboviteh V, Gafni M, and Same Y (2003) The stimulatory effect of cainiabinoids on calcium uptake is mediated by Gs GTP-binding proteins and cAMP formation. Neurosignals 12:39-44.
2. Bernath S (1992) Calcium-independent release of amino acid neurotransmitters: fact or artifact? Prog Neurobiol 38:57-91.
3. Bonhaus DW, Chang LK, Kwan J, and Martin GR (1998) Dual activation and inhibition of adenylyl cyclase by camiabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. J Pharmacol Exp Ther 287:884-888.
4. 2+ channels and modulate transmitter release in descending turtle spinal cord terminal synapsing motoneurons. J Comp Neurol 503:642-654.
5. Cooper AJ and Stanford IM (2001) Dopamme D2 receptor mediated presynaptic inhibition of striatopallidal GABA(A) IPSCs in vitro. Neuropharmacology 41:62-71.
6. Di Marzo V, Hill MP, Bisogno T, Grossman AR, and Brotchie JM (2000) Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J 14:1432-1438.
7. Felder CC, Joyce KE, Briley EM, Glass M, Mackie KP, Fahey KJ, Cullinan GJ, Hunden DC, Johnson DW, Chaney MO, et al. (1998) LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. J Pharmacol Exp Ther 284:291-297.
8. Florán B, Florán L, Erlij D, and Aceves J (2004) Activation of dopamme D4 receptorsm odulates GABA release in slices of the rat thalamic reticular nucleus. Neuropharmacology 46:497-503.
9. Floran B, Gonzalez B, Florán L, Erlij D, and Aceves J (2005) Interactions between adenosine A(2a) and dopamine D2 receptors in the control of GABA release in the globus pallidus of the rat. Eur J Pharmacol 520:43-50.
10. Gerfen CR and Young WS 3rd (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460: 161-167.
11. Glass M, Dragunow M, and Faull RL (2000) The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience 97:505-519.
12. Glass M and Felder CC (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci 17:5327-5333.
13. Gonzalez B, Escartm-Perez E, Aceves J, Florán B, and Erlij D (2006) Change, to Gsprotein coupling of CB1 receptors by concurrent activation ofD2 receptors inGABAergic terminals of the rat globus pallidus (Abstract). Soc Neurosci Abstr 32:923.8.
14. Gonzalez B, Floran L, Sierra A, Aceves J, Erlij D, and Floran B (2004) Facilitation and inhibition of GABAergic neurotransmission in the rat globus pallidus by CB1 receptors (Abstract). Soc Neurosci Abstr 30:623.11.
15. Gonzalez B, Paz F, Florán L, Aceves J, Erlij D, and Florán B (2006) Adenosine A2A receptor stimulation decreases GAT-1-mediated GABA uptake in the globus pallidus of the rat. Neuropharmacology 51:154-159.
16. Herkenham M, Lynn AB, de Costa BR, and Richfield EK (1991a) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res 547:267-274.
17. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, and Rice KG (1991b) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563-583.
18. Hermann H, Marsicano G. and Lutz B (2002) Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 109:451-460.
19. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, et al. (2002) International Union of Pharmacology: XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202.
20. Jarrahian A, Watts VJ, and Barker EL (2004) D2 dopamine receptors modulate Galpha-subunit coupling of the CB1 cannabinoid receptor. J Pharmacol Exp Ther 308:880-886.
21. Jin XT and Smith Y (2007) Activation of presynaptic kainate receptors suppresses GABAergic synaptic transmission in the rat globus pallidus. Neuroscience 149:338-349.
22. Kearn CS, Blake-Palmer K, Daniel E, Mackie K, and Glass M (2005) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol Pharmacol 67:1697-1704.
23. Köfalvi A, Rodrigues RJ, Ledent C, Mackie K, Vizi ES, Cunha RA, and Sperlagh B (2005) Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J Neurosci 25:2874-2884.
24. Maejima T, Ohno-Shosaku T, and Kano M (2001) Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals. Neurosci Res 40:205-210.
25. Mailleux P and Vanderhaeghen JJ (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:655-668.
26. Maneuf YP, Nash JE, Grossman AR, and Brotchie JM (1996a) Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus. Eur J Pharmacol 308:161-164.
27. Maneuf YP', Grossman AR, and Brotchie JM (1996b) Modulation of GABAergic transmission in the globus pallidus by the synthetic cannabinoid WIN 55,212-2. Synapse 22:382-385.
28. Mátyás F, Yanovsky Y, Mackie K, Kelsch W, Misgeld U, and Freund TF (2006) Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience 137:337-361.
29. Meschler JP and Howlett AC (2001) Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology 40:918-926.
30. Miller AS and Walker JM (1998) Local effects of cannabinoids on spontaneous activity and evoked inhibition in the globus pallidus. Eur J Pharmacol 352:199-205.
31. 3H]GABA release in substantia nigra pars reticulata. Neuropharmacology 53: 631-637.
32. Offermanns S (2003) G-proteins as transducers in transmembrane signalling. Prog Biophys Mol Biol 83:101-130.
33. Prather PL, Martin NA, Breivogel CS, and Childers SR (2000) Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies. Mol Pharmacol 57:1000-1010.
34. Romero J, de Miguel R, Ramos JA, and Fernández-Ruiz JJ (1998) The activation of cannabinoid receptors in striatonigral neurons inhibited GABA uptake. Life Sci 62:351-363.
35. Romero J, Lastres-Becker I, de Miguel R, Berrendero F, Ramos JA, and Fernández-Ruiz J (2002) The endogenous cannabinoid system and the basal ganglia, biochemical, pharmacological, and therapeutic aspects. Pharmacol Ther 95:137-152.
36. Sañudo-Peña MC, Romero J, Seale GE, Fernandez-Ruiz JJ, and Walker JM (2000) Activational role of cannabinoids on movement. Eur J Pharmacol 391:269-274.
37. Schlicker E and Kathmann M (2001) Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22:565-572.
38. 2+ channels by PTX-sensitive G-proteins is blocked by N-ethylmaleimide in rat sympathetic neurons. J Neurosci 14:7109-7116.
39. Shindou T, Nonaka H, Richardson PJ, Mori A, Kase H, and Ichimura M (2002) Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via a cyclic AMP dependent mechanism in the rat globus pallidus. Br J Pharmacol 136:296-302.
40. Strömberg I and Bickford-Wimer P (1991) Effects of locally applied Dl and D2 agonists on striatal neurons with 6-OHDA and pertussis toxin lesions. Brain Res 564:279-285.
41. Venderova K, Brown TM, and Brotchie JM (2005) Differential effects of endocannabinoids on -GABA uptake in the rat globus pallidus. Exp Neurol 194:284-287.
42. Wickens AP and Pertwee RG (1993) A9-Tetraliydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats. Eur J Pharmacol 250:205-208.